HAE On Other Exchanges
Symbol
Exchange
Xetra
London

haemato ag (HAE) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for HAEMATO AG (HAE)
\

Related News

No related news articles were found.

haemato ag (HAE) Related Businessweek News

No Related Businessweek News Found

haemato ag (HAE) Details

HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. The company distributes European import medicinal products; and manufactures and distributes its own generic medicinal products. It provides pharmaceuticals in the areas of oncology, HIV, rheumatism, neurology, and cardiovascular diseases; and products for aesthetic treatments. The company also develops and commercializes pharmaceutical, medicinal, and medical engineering products for aesthetic surgery and cosmetic dermatology. It serves wholesalers and pharmacies, as well as doctors and hospitals. The company was founded in 1993 and is based in Schönefeld, Germany. HAEMATO AG is a subsidiary of MPH Health Care AG.

194 Employees
Last Reported Date: 05/8/19
Founded in 1993

haemato ag (HAE) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

haemato ag
HAEMATO AG to Report Q1, 2019 Results on May 20, 2019

HAEMATO AG announced that they will report Q1, 2019 results on May 20, 2019

HAEMATO AG, Q1 2019 Earnings Call, May 20, 2019

HAEMATO AG, Q1 2019 Earnings Call, May 20, 2019

Haemato Ag Reports Earnings Results for the Full Year Ended December 31, 2018

HAEMATO AG announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was EUR 274.120 million compared to EUR 289.435 million a year ago. Operating income was EUR 8.503 million compared to EUR 9.389 million a year ago. Net income was EUR 6.276 million compared to EUR 6.957 million a year ago. Basic earnings per share was EUR 0.27 compared to EUR 0.32 a year ago.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

HAE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for HAE.
View Industry Companies
 

Industry Analysis

HAE

Industry Average

Valuation HAE Industry Range
Price/Earnings 11.4x
Price/Sales 0.3x
Price/Book 1.0x
Price/Cash Flow 9.4x
TEV/Sales 0.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact HAEMATO AG, please visit www.haemato.ag. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.